The B-cell surface protein CD72/Lyb-2 is the ligand for CD5

Area of Science:

• Immunology
• Cell Biology
• Molecular Interactions

Background:

• The glycoprotein CD5 is present on mature T cells and some B lymphocytes, but its precise function in immune responses remains unclear.
• Existing research suggests CD5 acts as a co-stimulatory receptor for T cells, analogous to CD2 and CD28.
• Antibodies targeting CD5 can trigger T cell proliferation, interleukin-2 secretion, and calcium influx, indicating its role in T cell activation.

Purpose of the Study:

• To identify the specific ligand that binds to the CD5 protein.
• To elucidate the molecular interaction between CD5 and its binding partner.

Main Methods:

• Purification and biotinylation of human CD5 protein to create a molecular probe.
• Utilizing the labeled CD5 probe to identify interacting cell-surface proteins.
• Employing anti-CD72 antibodies to block CD5-CD72 interactions and testing binding of CD72-transfected non-B cells to CD5.

Main Results:

• CD5 specifically binds to CD72, a cell-surface protein found exclusively on B cells.
• This interaction is inhibited by anti-CD72 antibodies, confirming specificity.
• Non-B cells engineered to express human CD72 demonstrated binding to the CD5 probe, further validating the interaction.

Conclusions:

• The B-cell surface protein CD72 is identified as the specific ligand for CD5.
• This finding establishes a direct molecular link between T cells (via CD5) and B cells (via CD72).
• Understanding this CD5-CD72 interaction provides new insights into cell-cell communication within the immune system.